EdgeRock Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,058
Closed -$205K 135
2026
Q1
$205K Sell
2,058
-68
-3% -$7.68K 0.06% 125
2025
Q4
$266K Sell
2,126
-9
-0.4% -$1.15K 0.07% 109
2025
Q3
$286K Sell
2,135
-210
-9% -$27.6K 0.08% 95
2025
Q2
$319K Buy
2,345
+654
+39% +$86.2K 0.1% 78
2025
Q1
$224K Buy
+1,691
New +$215K 0.16% 67
2024
Q1
Sell
-941
Closed -$106K 58
2023
Q4
$106K Buy
+941
New +$94K 0.08% 74
2022
Q4
Sell
-295
Closed -$29K 62
2022
Q3
$29K Buy
+295
New +$31.4K 0.02% 132

Other funds holding ABT

EdgeRock Capital's ABT Position: Q2 2026 in Review

EdgeRock Capital sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,058 shares — an estimated $205K sold.

EdgeRock Capital first reported a position in ABT in Q3 2022 and held it in 7 quarters. The position peaked at $319K in Q2 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • EdgeRock Capital reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • EdgeRock Capital sold 2,058 Abbott shares in Q2 2026, an estimated $205K.
  • EdgeRock Capital first reported a position in Abbott in Q3 2022 and held it in 7 quarters.
  • EdgeRock Capital's Abbott position peaked at $319K in Q2 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on EdgeRock Capital's 13F filing for Q2 2026, filed 24 Jul 2026.